Space ExplorationSPCX

Business Snapshot

• SPCX is listed as a US common stock on NASDAQ and is linked in the supplied SEC data to Space Exploration Technologies Corp.
• The payload does not provide a sector, industry description, business segments, valuation multiples, earnings guidance, or analyst targets.
• The shares have risen sharply over the available 172 daily bars: from an open of $25.535 to a current price of $164.08, a gain of 542.57%. The session range is unusually wide at $21.32–$225.64, indicating substantial price volatility.

Financial Trends

• Revenue: The latest reported period, June 30, 2026, showed revenue of $7.814 billion versus $4.071 billion on June 30, 2025, an increase of $3.743 billion, or approximately 92%. Only two income-statement periods are supplied, so a four-period quarterly revenue trajectory cannot be established.
• Operating performance: Operating loss narrowed from $970 million to $143 million, an improvement of $827 million. The operating margin improved from -23.83% to -1.83%, a 22.00-percentage-point improvement.
• Net income: Net loss improved from $1.008 billion to $541 million, a reduction of $467 million. Net margin improved from -24.76% to -6.92%, a 17.84-percentage-point improvement. The company remained loss-making.
• Shares and EPS: Diluted EPS improved from -$0.34 to -$0.09, while diluted weighted-average shares increased from 2.929 billion to 5.864 billion, an increase of 2.935 billion shares, or about 100%. The share increase is important when assessing per-share progress and potential dilution.
• Cash flow: Operating cash flow increased from $351 million to $3.466 billion, up $3.115 billion. However, capital expenditures increased from $6.965 billion to $28.476 billion, and free cash flow deteriorated from -$6.614 billion to -$25.010 billion, a decline of $18.396 billion. The latest period therefore shows sharply stronger operating cash generation but substantially heavier investment spending.
• Balance sheet: Cash increased from $24.747 billion at December 31, 2025, to $93.522 billion at June 30, 2026, a gain of $68.775 billion. Total assets increased from $92.079 billion to $192.770 billion, while total liabilities rose from $50.754 billion to $65.546 billion. Equity rose from $2.573 billion to $127.224 billion. These changes are large, but the dataset does not provide the March and June 2026 balance-sheet values needed for a complete four-period progression.
• Liquidity and leverage: The current ratio improved from 1.45 at December 31, 2025, to 5.12 at June 30, 2026. Working capital increased from $9.552 billion to $86.925 billion, while debt/equity fell from 8.54 to 0.29. The direction is materially stronger, although the underlying balance-sheet changes should be reviewed against the full filings because several intermediate fields are missing.

Financial Health

• The latest period shows a mixed but improving operating profile: revenue nearly doubled year over year, operating and net losses narrowed substantially, and operating cash flow strengthened.
• Liquidity and reported leverage improved considerably. Cash of $93.522 billion and a 5.12 current ratio provide a much larger reported liquidity buffer than at December 31, 2025.
• The key financial risk is cash deployment. Free cash flow was negative $25.010 billion because capital expenditures reached $28.476 billion. Strong cash reserves reduce near-term liquidity pressure, but sustained investment spending could continue to weigh on cash generation.
• Retained earnings remained deeply negative at -$41.852 billion, worsening from -$37.035 billion at December 31, 2025. Despite balance-sheet strengthening, the company has not yet established positive cumulative retained earnings.
• The company remains unprofitable, and the large increase in diluted shares means improving total-company results have not necessarily translated into equivalent per-share improvement.

Insider Activity

• Insider sentiment for July 14–October 12, 2026, was Neutral (-8).
• Reported buys totaled $6.50 million across five transactions, while sells totaled $52.55 million across ten transactions, producing net selling of $46.05 million.
• On September 22, Gwynne Shotwell reported purchases totaling approximately $6.50 million at prices of $8.40, $11.20, and $19.40, alongside sales totaling approximately $52.55 million at prices between $151.15 and $154.72.
• The reported activity is therefore heavily sell-weighted by dollar value, even though there were insider purchases. The transaction data includes entries with zero-dollar transfers, so those should not be interpreted as market-price sales.
• Antonio J. Gracias also has a reported September 11 sale of 42,790,223 Class A shares, but the payload does not provide a transaction value or price. Insider data is a risk signal rather than a standalone timing indicator.

Multi-Timeframe Technical Context

• Ultra-short horizon — minutes: Intraday candle and indicator data are not supplied. The displayed session range of $21.32–$225.64 is exceptionally broad relative to the $164.08 current price, so execution risk and sharp reversals appear elevated. Minute-level support, resistance, and volume behavior cannot be confirmed.
• Short horizon — hours to days: The daily RSI readings are constructive but not extreme: RSI-14 is 58.15 and RSI-21 is 57.82. MACD is positive at 5.68 versus a 5.04 signal line, indicating positive momentum, though the narrow spread suggests momentum is not accelerating strongly.
• The current price is above the 12-day EMA of $159.93, 26-day EMA of $154.25, 50-day EMA of $145.09, and 20-day SMA of $155.20. This preserves a bullish moving-average structure.
• At $164.08, the stock is above the Bollinger middle band of $155.20 but below the upper band of $172.22. That places price in the upper half of the recent daily range without yet reaching the supplied upper volatility boundary.
• Current volume of 39.24 million is below the 20-day average of 94.35 million, approximately 58% of average. The latest move therefore lacks confirmation from above-average volume in the supplied data.
• Long horizon — weeks to months: The 172-bar advance of 542.57% establishes a powerful long-term uptrend, but the very large historical range and current price volatility imply elevated drawdown risk. The positive EMA/SMA alignment supports the trend, while the distance from the longer moving averages leaves the stock vulnerable to mean reversion if momentum fails.

Bull / Bear Cases

• Short-term bull case: Price remains above $159.93 and $155.20, MACD remains above its signal line, and RSI stays below overbought territory. A move through the $172.22 upper Bollinger band, especially with volume recovering toward or above the 94.35 million 20-day average, would indicate renewed upside momentum.
• Short-term bear case: Failure to hold the $159.93–$155.20 area could pull price toward the $154.25 26-day EMA and then the $145.09–$145.35 50-day EMA/SMA zone. Below those levels, the recent advance would be technically weakened. The unusually wide session range increases the probability of abrupt downside moves.
• Long-term bull case: Revenue growth, narrowing operating and net losses, stronger operating cash flow, materially higher cash, improved current ratio, and lower reported debt/equity all support a longer-term improvement thesis. Continued operating leverage could eventually move the company toward profitability.
• Long-term bear case: The company remains loss-making, free cash flow is deeply negative, capital expenditures have expanded sharply, retained earnings remain negative, and diluted shares approximately doubled year over year. Insider activity is also materially sell-weighted by dollar value. A valuation or momentum reset could be severe after a 542.57% advance, particularly if investment spending does not translate into further revenue and margin improvement.

Key Levels & Triggers

• Current price: $164.08.
• Immediate upside reference: $172.22, the daily upper Bollinger band. A sustained break above it would be a momentum trigger, but confirmation from stronger volume would improve reliability.
• First support zone: $159.93, the 12-day EMA.
• Secondary support zone: $155.20, the 20-day SMA and Bollinger middle band.
• Additional support: $154.25, the 26-day EMA.
• Major trend support: Approximately $145.09–$145.35, represented by the 50-day EMA and 50-day SMA.
• Momentum triggers: MACD remaining above its $5.04 signal line and RSI holding near or above the current 58 area would support trend continuation. A bearish MACD crossover or sustained RSI deterioration would weaken the setup.
• Fundamental triggers: Further revenue growth, continued narrowing of operating and net losses, and a reduction in negative free cash flow would strengthen the long-term thesis. Conversely, persistently large capital expenditures, renewed margin deterioration, additional dilution, or continued heavy insider selling would increase risk.
• No earnings calendar, forward guidance, valuation data, or additional intraday timeframes were provided, so those catalysts cannot be assessed.